Capital One
COF
$206.68
-0.78%
Capital One Financial is a diversified financial-services holding company whose core business centers on credit card lending, auto loans, and commercial lending, with a smaller personal loan book following its 2025 acquisition of Discover Financial. The company is one of the largest U.S. card issuers and a scaled consumer-banking platform, distinguished by its data-driven underwriting and its newly acquired Discover payments network, which gives it a closed-loop card ecosystem comparable to the largest integrated issuers. The current investor narrative is dominated by the Discover integration, which management says is on track and could unlock roughly 15% earnings accretion by 2027 through cost savings and revenue synergies, even as reported earnings remain noisy due to acquisition-related charges. That optimism is tempered by a messy reported earnings picture — a large Q2 2025 loss tied to deal accounting, a Q1 2026 revenue beat but EPS miss, and a stock that has lagged the market badly over the past year despite a strong recent rebound. Rising subprime auto delinquencies are also in focus, though Capital One's disciplined underwriting is widely viewed as a relative advantage versus higher-risk lenders.…
COF
Capital One
$206.68
Related headlines
Investment Opinion: Should I buy COF Today?
Rating: Buy. The core thesis is that Capital One is a deeply undervalued large-cap financial trading at 8.66x forward earnings with a clear path to 15% earnings accretion from the Discover acquisition, while the market is overly focused on near-term integration noise. The consensus analyst rating is Buy (mean 1.54) with an average target price of $258.27, implying 24% upside from the current price of $208.30. Supporting evidence includes: (1) revenue grew 44.1% year-over-year in Q1 2026 to $19.32 billion, (2) gross margin recovered to 57.79% from 6.99% in the loss-making Q2 2025, (3) trailing free cash flow is a robust $28.87 billion, and (4) the forward PE of 8.66x is well below the sector average and the stock's own historical range. The biggest risks are credit deterioration (subprime auto delinquencies at a 32-year high), integration execution (operating margin still below 14% vs. 22% in Q3 2025), and the stock's poor relative strength (down 23.37 percentage points versus SPY over one year). The rating would upgrade to Strong Buy if forward PE remains below 10x and credit costs stabilize, or downgrade to Hold if revenue growth decelerates below 10% or net charge-offs rise above 4%. Relative to its history and peers, COF appears undervalued on normalized earnings, but the market is pricing in significant uncertainty.
Sign up to view all
COF 12-Month Price Forecast
Capital One presents a compelling risk/reward for patient investors. The stock is deeply undervalued on normalized earnings, with a forward PE of 8.66x that is less than half its historical average. The Discover acquisition has already transformed the revenue base, and management's target of 15% earnings accretion by 2027 is credible given the $28.87 billion in free cash flow and strong capital position. However, the bear case cannot be ignored: subprime auto delinquencies are at a 32-year high, and the stock has underperformed the market by 23.37 percentage points over the past year. The wide analyst target range ($214–$300) reflects genuine uncertainty. I would upgrade to high confidence if Q2 2026 earnings show margin expansion and credit stabilization; I would downgrade to neutral if charge-offs rise above 4% or if integration costs exceed guidance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Capital One's 12-month outlook, with a consensus price target around $258.27 and implied upside of +25.0% versus the current price.
Average Target
$258.27
0 analysts
Implied Upside
+25.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$214 - $300
Analyst target range
Coverage is robust, with 22 analysts following COF and a consensus recommendation of Buy (recommendation mean of 1.54, where 1.0 is a Strong Buy). The average target price is $258.27, implying roughly 24.0% upside from the current price of $208.30, and the consensus leans clearly bullish. The estimated forward EPS average of $39.17 and estimated revenue average of $78.64 billion support the constructive view, with the revenue estimate range of $77.02 billion to $80.64 billion suggesting relatively tight agreement on the top line. The bullish consensus is notable given the stock's poor one-year performance, indicating that analysts see the weakness as temporary and tied to integration noise rather than deteriorating fundamentals. The target range is wide, from a low of $214.00 to a high of $300.00, a spread of $86.00 that signals meaningful disagreement about the pace and magnitude of the earnings recovery. The low target of $214.00 implies just 2.7% upside and likely prices in slower synergy realization, elevated credit costs, or a recession scenario that pressures card losses. The high target of $300.00 implies about 44% upside and assumes full Discover synergy capture, multiple expansion toward peer levels, and accelerating earnings growth. Recent institutional actions skew positive: HSBC upgraded to Buy from Hold in July 2026, Piper Sandler upgraded to Overweight from Neutral in June 2026, and firms including JP Morgan, B of A, TD Cowen, and UBS have maintained Buy or Overweight ratings. The tight clustering of upgrades and reiterations around mid-2026 suggests analysts are becoming more confident in the recovery story, though the wide target spread means conviction on the magnitude of upside remains uneven.
Drowning in data?
Find the real signal!
Bulls vs Bears: COF Investment Factors
The bull case rests on a powerful earnings recovery: forward PE of 8.66x, 44% revenue growth, $28.87 billion in free cash flow, and a consensus Buy rating with 24% upside to the average target. The bear case centers on messy reported earnings, a 23.37 percentage point underperformance versus SPY over one year, and rising subprime delinquencies that could pressure credit costs. Currently, the bull evidence is stronger because the valuation disconnect is extreme and the Discover synergies are tangible, but the bear case cannot be dismissed given the stock's technical weakness and the wide analyst target spread. The single most important tension is whether the Discover integration will deliver the promised 15% earnings accretion by 2027; if it does, the stock is deeply undervalued, but if integration stalls or credit deteriorates, the forward PE of 8.66x could prove to be a value trap.
Bullish
- Deep Value on Normalized Earnings: Forward PE of 8.66x is exceptionally low for a large-cap card issuer with 44% revenue growth, and the gap between trailing PE (60.14x) and forward PE signals the market expects earnings to normalize sharply. Analyst EPS estimates of $39.17 imply a massive recovery from trailing EPS of $0.019, and if realized, the stock trades at a fraction of its historical multiple range (5.0x–25.1x).
- Discover Synergies Could Add 15% to Earnings: Management says the Discover integration is on track to unlock roughly 15% earnings accretion by 2027 through cost savings and revenue synergies. Q1 2026 revenue of $19.32 billion already reflects a step-change from $13.41 billion a year earlier, and the fee-based streams (interchange of $3.15 billion) are exactly the high-margin revenue the deal was designed to expand.
- Strong Analyst Consensus with 24% Upside: 22 analysts cover COF with a consensus Buy rating (mean 1.54) and an average target price of $258.27, implying 24.0% upside from $208.30. Recent upgrades from HSBC (July 2026) and Piper Sandler (June 2026) suggest growing confidence in the recovery story despite the stock's poor one-year performance.
- Robust Cash Flow and Solid Balance Sheet: Trailing free cash flow is $28.87 billion, and Q1 2026 operating cash flow of $6.02 billion dwarfs capital expenditure of just $553 million. Debt-to-equity is a modest 0.45, and cash on hand of $79.26 billion provides ample liquidity to fund integration and absorb credit normalization without external financing.
Bearish
- Earnings Quality Remains Messy and Unpredictable: Q1 2026 EPS of $3.34 missed estimates, following a massive Q2 2025 loss of $4.28 billion tied to deal accounting. Trailing net margin is just 3.54% and ROE is a depressed 2.16%, highlighting that reported profitability is still far below normalized levels and highly sensitive to integration charges.
- Severe Underperformance and Weak Technicals: COF is down 7.15% over the past year and down 15.98% year-to-date, massively underperforming SPY by 23.37 percentage points over one year. The stock sits at only 40% of its 52-week range ($174.24–$259.64) and remains 24.6% below its 52-week high, with the 31.73% maximum drawdown underscoring the risk.
- Credit Risk from Rising Subprime Delinquencies: Subprime auto loan delinquencies have reached their worst level in 32 years, which could pressure Capital One's auto and card loss rates. While COF is viewed as disciplined, any acceleration in charge-offs would directly hit net income, which is already thin at an 11.25% net margin in Q1 2026.
- Integration Execution Risk and Cost Drag: Operating margin of 13.97% in Q1 2026 is well below the 22.11% reported in Q3 2025, reflecting the drag from integration and higher credit costs. If synergies are delayed or cost savings fall short, the earnings recovery implied by the 8.66x forward PE may not materialize, leaving the stock vulnerable.
COF Technical Analysis
COF is in a recovery phase within a broader range-bound structure: the stock is up 15.86% over six months but down 7.15% over the past year and down 15.98% year-to-date, a divergence that reflects a sharp drawdown followed by a powerful rebound. At $208.30, the shares sit at roughly 40% of the 52-week range (low $174.24, high $259.64), meaning they are much closer to the annual low than the high despite the recent rally — a positioning that offers value but also confirms the stock has not reclaimed its prior uptrend. The 52-week high of $259.64 remains about 24.6% above the current price, so overhead supply from earlier in the year is a real technical obstacle. Momentum is mixed and decelerating: the stock is up 12.76% over three months but down 6.36% over the past month, a clear short-term pullback within the medium-term recovery. Relative strength tells the same story — COF has outperformed SPY by 9.72 percentage points over three months but underperformed by 5.30 points over the past month and by a striking 23.37 points over the past year. This one-month weakness against a roughly flat market (SPY -1.06%) suggests profit-taking after the summer rally rather than a fundamental breakdown, but it does signal that near-term momentum has cooled. Key support sits at the 52-week low of $174.24, about 16.4% below the current price, while resistance is the $259.64 high; a breakout above the recent $227 area (the August peak) would re-establish the uptrend, whereas a breakdown below $200 would put the $174 low back in play. With a beta of 1.016, COF moves roughly in line with the market, so position sizing does not require unusual volatility adjustment, though the 31.73% maximum drawdown over the past year underscores that this is not a low-risk holding.
Beta
1.02
1.02x market volatility
Max Drawdown
-31.7%
Largest decline past year
52-Week Range
$174-$260
Price range past year
Annual Return
-7.6%
Cumulative gain past year
| Period | COF Return | S&P 500 |
|---|---|---|
| 1m | -9.1% | -2.0% |
| 3m | +3.0% | +1.4% |
| 6m | +14.7% | +15.0% |
| 1y | -7.6% | +15.7% |
| ytd | -16.6% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COF Fundamental Analysis
Revenue is growing strongly, driven by the Discover acquisition: Q1 2026 revenue was $19.32 billion, up 44.1% year-over-year from $13.41 billion in Q1 2025, and the multi-quarter trend shows a step-change higher from the $16.41 billion reported in Q2 2025. Sequentially, revenue has been roughly flat around $19.3-19.8 billion over the past three quarters ($19.82 billion in Q3 2025, $19.61 billion in Q4 2025, $19.32 billion in Q1 2026), indicating the initial acquisition-driven surge has normalized into a stable base. Within the revenue mix, interchange fees of $3.15 billion and other contract revenue of $398 million highlight the fee-based, network-enabled earnings streams that the Discover deal was designed to expand. The key question for investors is whether this larger revenue base can be converted into durable earnings growth as integration costs roll off. Profitability is positive but thin at the net level: Q1 2026 net income was $2.17 billion on $19.32 billion of revenue, a net margin of 11.25%, while the trailing net margin is just 3.54% because of the Q2 2025 loss of $4.28 billion. Gross margin was 57.79% in Q1 2026, up from 57.36% in Q4 2025 and 6.99% in the loss-making Q2 2025, showing a clear recovery in underlying economics. Operating margin of 13.97% in Q1 2026 is well below the 22.11% reported in Q3 2025, reflecting the drag from integration and higher credit costs, but the direction of travel from the Q2 2025 trough (-36.13% operating margin) is decisively positive. The balance sheet is solid for a large bank: debt-to-equity is a modest 0.45, ROE is 2.16% (depressed by the acquisition accounting), and free cash flow is robust at $28.87 billion on a trailing basis. Q1 2026 operating cash flow was $6.02 billion against capital expenditure of just $553 million, and the company returned capital via $2.79 billion of buybacks and $559 million of dividends. Cash on hand is substantial at $79.26 billion, up from $62.09 billion at year-end 2025, giving the firm ample liquidity to fund integration and absorb credit normalization without external financing.
Quarterly Revenue
$19.3B
2026-03
Revenue YoY Growth
+44.1%
YoY Comparison
Gross Margin
57.8%
Latest Quarter
Free Cash Flow
$28.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COF Overvalued?
Because Capital One is profitable on a net-income basis, the PE ratio is the appropriate primary metric, but the trailing figure is distorted by the Q2 2025 loss: the trailing PE is 60.14x while the forward PE is just 8.66x, an enormous gap that signals the market expects earnings to normalize sharply as Discover synergies materialize. The forward PE of 8.66x is exceptionally low in absolute terms and implies the market is pricing in a full recovery in earnings power, with estimated EPS of $39.17 for the forward period versus the current trailing EPS of $0.019. This disconnect is the central valuation debate: either the market is underestimating the earnings recovery, or it is discounting credit risk and integration uncertainty. On a price-to-book basis, COF trades at 1.15x, a modest premium to book that is reasonable for a large card issuer with improving returns. Relative to the broader financial services sector, COF's forward PE of 8.66x screens cheap, and its PS ratio of 1.89x and EV/Sales of 2.71x are also undemanding for a company of its scale. The premium/discount assessment is complicated by the fact that the trailing multiples are inflated by one-time acquisition charges, so the forward multiples are the more meaningful comparison; on that basis, COF appears to trade at a discount to peers with similar growth, which the market may be justifying through credit-quality concerns. Historically, COF's PE has ranged widely — from 5.0x in mid-2022 to 25.1x in mid-2024 — and the current trailing 60.14x is an outlier driven by the depressed earnings base, while the forward 8.66x sits near the lower end of the historical band. The PB ratio of 1.15x is above the 0.67-0.96x range seen in 2022-2023 but below the 1.35x at year-end 2025, suggesting the stock is neither historically cheap nor expensive on book value. Net-net, the valuation looks attractive on normalized earnings but requires confidence that the Discover integration and credit normalization proceed as planned.
PE
60.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company's trailing net margin is just 3.54% and ROE is a depressed 2.16%, reflecting the drag from the Q2 2025 loss of $4.28 billion and ongoing integration costs. While free cash flow is robust at $28.87 billion, the payout ratio is 72.1%, leaving little room for error if earnings do not recover as expected. Additionally, the current ratio of 0.146 is very low, indicating potential liquidity tightness in the short term, though this is typical for banks with large loan books. The debt-to-equity of 0.45 is manageable, but any deterioration in credit quality could quickly erode capital. Market and competitive risks are also material. COF trades at a forward PE of 8.66x, which is cheap, but the trailing PE of 60.14x and PB of 1.15x suggest the market is pricing in a full recovery. If peers like American Express or JPMorgan continue to gain share in the premium card space, Capital One's growth could stall. The beta of 1.016 means the stock moves with the market, but its 31.73% maximum drawdown over the past year shows it is not defensive. Regulatory risks, such as potential caps on interchange fees or changes to credit card late fees, could pressure revenue. The worst-case scenario would be a recession that drives up unemployment, causing card and auto charge-offs to spike while integration costs remain high. In that scenario, the stock could retest its 52-week low of $174.24, representing a 16.4% decline from the current price of $208.30. If credit losses exceed expectations and the Discover synergies are delayed, the analyst low target of $214.00 could be breached, and the stock could fall further to $160–$170, implying a 20–25% downside. This would be a severe but not catastrophic loss for a large-cap financial, and the dividend yield of 1.35% would provide minimal cushion.
FAQ
The most severe risk is credit deterioration: subprime auto delinquencies have hit a 32-year high, and any acceleration in card charge-offs could directly hit net income, which is already thin at an 11.25% net margin. Second, integration execution risk: operating margin of 13.97% in Q1 2026 is well below the 22.11% in Q3 2025, and if Discover synergies are delayed, the earnings recovery implied by the 8.66x forward PE may not materialize. Third, valuation compression risk: while the forward PE is low, the trailing PE of 60.14x and PB of 1.15x leave room for further downside if earnings disappoint. Fourth, regulatory risk: potential caps on interchange fees or late fees could pressure revenue. Finally, macro sensitivity: with a beta of 1.016, COF is not defensive, and a recession would likely lead to a retest of the 52-week low of $174.24, a 16.4% decline.
Our 12-month forecast has three scenarios: bull case (30% probability) with a target range of $258–$300, assuming smooth integration and multiple expansion; base case (50% probability) with a target range of $230–$260, assuming EPS normalizes toward $39.17 and the stock trades up to the analyst average target of $258.27; and bear case (20% probability) with a target range of $174–$214, assuming a recession or credit deterioration that drives the stock back to its 52-week low. The base case is most likely, supported by the consensus analyst target and the company's strong free cash flow. The key assumption behind the base case is that Discover synergies contribute 10–15% to earnings by 2027 and net charge-offs stay below 4%.
COF appears undervalued on normalized earnings but fairly valued on book value. The forward PE of 8.66x is exceptionally low compared to the broader financial sector and the stock's own historical range of 5.0x–25.1x, suggesting the market is pricing in a full earnings recovery. The trailing PE of 60.14x is distorted by the Q2 2025 loss and should be ignored. On a price-to-book basis, COF trades at 1.15x, which is above the 0.67–0.96x range seen in 2022–2023 but below the 1.35x at year-end 2025, indicating a fair valuation. The PS ratio of 1.89x and EV/Sales of 2.71x are also undemanding for a company with 44% revenue growth. Overall, the market is paying a discount on earnings but a fair price on book, implying it expects the recovery but is not yet convinced.
From a risk/reward perspective, COF is a good buy for investors with a medium-to-long-term horizon and tolerance for volatility. The stock trades at a forward PE of 8.66x, implying 24% upside to the analyst average target of $258.27, and the Discover acquisition is on track to deliver 15% earnings accretion by 2027. However, the biggest downside risk is credit deterioration: subprime auto delinquencies are at a 32-year high, and the stock has a 31.73% maximum drawdown over the past year. For value-oriented investors who believe the earnings recovery will materialize, COF offers an attractive entry point near $208. For those seeking stability, the messy reported earnings and wide analyst target range ($214–$300) may be a deterrent.
COF is more suitable for long-term investment than short-term trading. The company is in the middle of a multi-year integration of Discover, with management targeting 15% earnings accretion by 2027, and the stock's 31.73% maximum drawdown over the past year shows it can be volatile in the short term. The beta of 1.016 means it moves with the market, but the messy reported earnings and wide analyst target range create uncertainty that is better resolved over a longer horizon. The dividend yield of 1.35% is modest but provides some income. A suggested minimum holding period is 2–3 years to allow the integration synergies to fully materialize and for credit conditions to normalize. Short-term traders may find opportunities around earnings announcements, but the risk/reward favors patient investors.